1. Home
  2. VHC vs IVVD Comparison

VHC vs IVVD Comparison

Compare VHC & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirnetX Holding Corp

VHC

VirnetX Holding Corp

HOLD

Current Price

$18.67

Market Cap

70.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$2.27

Market Cap

692.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHC
IVVD
Founded
2005
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.7M
692.7M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
VHC
IVVD
Price
$18.67
$2.27
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$8.33
AVG Volume (30 Days)
15.5K
12.0M
Earning Date
11-14-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$106,000.00
$50,039,000.00
Revenue This Year
N/A
$103.88
Revenue Next Year
N/A
$171.40
P/E Ratio
N/A
N/A
Revenue Growth
2020.00
332.71
52 Week Low
$3.68
$0.35
52 Week High
$29.00
$3.07

Technical Indicators

Market Signals
Indicator
VHC
IVVD
Relative Strength Index (RSI) 39.68 53.98
Support Level $18.13 $2.09
Resistance Level $23.70 $2.60
Average True Range (ATR) 1.89 0.22
MACD -0.63 -0.04
Stochastic Oscillator 5.52 17.86

Price Performance

Historical Comparison
VHC
IVVD

About VHC VirnetX Holding Corp

VirnetX Holding Corp is engaged in the business of commercializing a portfolio of patents. It is an Internet security software and technology company with patented technology for secure communications. The company's software and technology solutions, including its Secure Domain Name Registry and Technology, VirnetX One, War Room, VirnetX Matrix, and GABRIEL Connection Technology, are designed to be device and location-independent, and enable a secure real-time communication environment for all types of enterprise applications, services and critical infrastructures.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: